Press Releases |News

05/11/2017

Genomic Sequencing

Tempus and Northwestern Expand Partnership to Accelerate Personalized Medicine Efforts

Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University announce a second collaboration aimed at personalizing care for cancer patients.As part of the newest...

05/11/2017

Genomic Sequencing

Tempus and Northwestern Expand Partnership to Accelerate Personalized Medicine Efforts

Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University announce a second collaboration aimed at personalizing care for cancer patients. As part of the newest collaboration,...

04/27/2017

Genomic Sequencing

Tempus and Penn’s Abramson Cancer Center Expand Genomic Collaboration

Tempus, a technology company focused on helping doctors personalize cancer treatment by collecting, sorting and analyzing clinical and molecular data, has formed a second collaboration with Penn’s Abramson Cancer Center to improve and personalize treatment for patients diagnosed with acute myeloid leukemia (AML). AML is a cancer...

04/27/2017

Genomic Sequencing

Tempus Announces BRCA Focused Initiative in Partnership with Penn’s Basser Center for BRCA

Tempus, a technology company focused on helping doctors personalize cancer treatment by collecting, sorting and analyzing clinical and molecular data, has announced a new collaboration with cancer experts at the Basser Center for BRCA in the Abramson Cancer Center of the University of Pennsylvania to improve and personalize...

04/04/2017

Genomic Sequencing

Erik Phelps Joins Tempus as Executive Vice President and General Counsel

Tempus, a technology company that enables physicians to deliver personalized cancer care, has hired Erik Phelps to serve as Executive Vice President and General Counsel. Phelps will be responsible for a broad range of legal areas for the company, including general corporate matters and strategy. Prior to joining...

03/02/2017

Tempus Teams with Major Academic Medical Center to Advance Treatment Options for Patients Diagnosed with Aggressive Brain Cancer

Tempus, a technology company focused on helping doctors personalize cancer care by collecting, sorting and analyzing clinical and molecular data, announced that it will work with Duke University School of Medicine on an initiative to accelerate research and treatment for brain cancer. Scientists at the Preston Robert Tisch...

01/17/2017

Tempus And University Hospitals Seidman Cancer Center announce joint effort to customize treatment for cancer patients

Tempus, a technology company focused on helping doctors personalize cancer care, and University Hospitals Seidman Cancer Center have joined together to improve research and healthcare by making genomic data, advanced molecular analysis and clinical decision support tools available to the hospital's researchers, physicians and healthcare providers.As part...

01/09/2017

Genomic Sequencing

Dr. Gary Palmer joins Tempus as Chief Medical Officer

Tempus, a technology company that helps physicians deliver customized cancer care, has selected Dr. Gary Palmer to serve as the company's Chief Medical Officer. Palmer will be responsible for leading clinical activities for the company and supporting external collaborations and strategic partnerships. "Gary has spent the last 20 years...

10/31/2016

Genomic Sequencing

Tempus and Rush University Medical Center announce personalized medicine partnership

Tempus, a technology company focused on helping doctors personalize cancer care, and Rush University Medical Center announced today a partnership to pursue their shared goal of providing customized treatment to cancer patients."Technology has come a long way since the human genome was first mapped more than...

10/11/2016

Tempus And University of Michigan announce partnership for cancer patients

Tempus, a health-tech company focused on personalizing cancer care, and the University of Michigan Comprehensive Cancer Center have partnered to bring MI-ONCOSEQ to patients and health care providers across the country who are seeking the high quality data and analyses necessary to personalize treatment for their patients.The M...

NEWS

Press Releases

Media Coverage

Additional Partnerships

Blog

Tempus and Northwestern Expand Partnership to Accelerate Personalized Medicine Efforts

Tempus and Northwestern Expand Partnership to Accelerate Personalized Medicine Efforts

Tempus and Penn’s Abramson Cancer Center Expand Genomic Collaboration

Tempus Announces BRCA Focused Initiative in Partnership with Penn’s Basser Center for BRCA

Erik Phelps Joins Tempus as Executive Vice President and General Counsel

Tempus Teams with Major Academic Medical Center to Advance Treatment Options for Patients Diagnosed with Aggressive Brain Cancer

Tempus And University Hospitals Seidman Cancer Center announce joint effort to customize treatment for cancer patients

Dr. Gary Palmer joins Tempus as Chief Medical Officer

Tempus and Rush University Medical Center announce personalized medicine partnership

Tempus And University of Michigan announce partnership for cancer patients